Intrathecal agonists for inhibitory G coupled receptors (e.g. mu and alpha2) produce analgesia. Based on receptor distribution and block of afferent release (substance P: SP), we think the analgesia reflects a joint pre- and post-synaptic action. Neurokinin 1 receptor (NK1) internalization and cFos/pCREB expression are robust tools to define in vivo the effect of acute and chronic interventions on small afferent release and post synaptic excitability and to explore several hypothesized ramifications of this action. 1) IT analgesic activity will co-vary with the inhibitory effects on small afferent terminal excitability (NK1 internalization). We will examine in rats the effects/pharmacology of IT agents acting on small afferent terminal receptors (mu, delta, alpha2, NPY, GABAB, and Adenosine A1) to block paw injury evoked NK1 internalization. 2) Spinal receptors located postsynaptic to the primary afferent will control excitatory outflow of spinal neurons driven by afferent input. Using cFos/pCREB expression, paw injury, IT-SP or IT-NMDA will be used to activate spinal neurons and indirectly supraspinal neurons (n. parabrachialis) in the presence of IT-analgesics. 3) Systemic morphine exerts its effect upon spinal function by concurrent spinal and supraspinal actions. We will examine the spinal effects of intracerebral and systemically administered morphine at analgesic doses on spinal NK1 internalization and activation of spinal/supraspinal cFos/pCREB by paw injury, IT SP or IT NMDA. 4) Given tolerance and dependence observed with chronic IT mu and alpha2 agonists and the proposed sensitization of spinal processing mediated though NMDA and PKC, we hypothesize that i) chronic IT mu or alpha2 agonist infusion will enhance injury evoked NK1 internalization and increased IT SP-evoked cFos activation at spinal and supraspinal levels;ii) increased NK1 internalization and cFos after naloxone;and iii) a reversal of mu tolerance with NMDA antagonism or PKC inhibition. In short, these studies seek to illuminate the complex pre- and postsynaptic mechanisms by which modulatory receptors regulate spinal nociceptive outflow.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA002110-29
Application #
7565932
Study Section
Somatosensory and Chemosensory Systems Study Section (SCS)
Program Officer
Aigner, Thomas G
Project Start
1983-07-01
Project End
2010-01-31
Budget Start
2009-02-01
Budget End
2010-01-31
Support Year
29
Fiscal Year
2009
Total Cost
$287,127
Indirect Cost
Name
University of California San Diego
Department
Anesthesiology
Type
Schools of Medicine
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Gregus, Ann M; Buczynski, Matthew W; Dumlao, Darren S et al. (2018) Inhibition of spinal 15-LOX-1 attenuates TLR4-dependent, nonsteroidal anti-inflammatory drug-unresponsive hyperalgesia in male rats. Pain 159:2620-2629
Podvin, Sonia; Yaksh, Tony; Hook, Vivian (2016) The Emerging Role of Spinal Dynorphin in Chronic Pain: A Therapeutic Perspective. Annu Rev Pharmacol Toxicol 56:511-33
Park, H J; Sandor, K; McQueen, J et al. (2016) The effect of gabapentin and ketorolac on allodynia and conditioned place preference in antibody-induced inflammation. Eur J Pain 20:917-25
Woller, Sarah A; Ravula, Satheesh B; Tucci, Fabio C et al. (2016) Systemic TAK-242 prevents intrathecal LPS evoked hyperalgesia in male, but not female mice and prevents delayed allodynia following intraplantar formalin in both male and female mice: The role of TLR4 in the evolution of a persistent pain state. Brain Behav Immun 56:271-80
Sikandar, Shafaq; Gustavsson, Ynette; Marino, Marc J et al. (2016) Effects of intraplantar botulinum toxin-B on carrageenan-induced changes in nociception and spinal phosphorylation of GluA1 and Akt. Eur J Neurosci 44:1714-22
Pellett, Sabine; Yaksh, Tony L; Ramachandran, Roshni (2015) Current status and future directions of botulinum neurotoxins for targeting pain processing. Toxins (Basel) 7:4519-63
Woller, S A; Corr, M; Yaksh, T L (2015) Differences in cisplatin-induced mechanical allodynia in male and female mice. Eur J Pain 19:1476-85
Ramachandran, Roshni; Lam, Carmen; Yaksh, Tony L (2015) Botulinum toxin in migraine: Role of transport in trigemino-somatic and trigemino-vascular afferents. Neurobiol Dis 79:111-22
Ramachandran, Roshni; Yaksh, Tony L (2014) Therapeutic use of botulinum toxin in migraine: mechanisms of action. Br J Pharmacol 171:4177-92
Park, Hue Jung; Stokes, Jennifer A; Corr, Maripat et al. (2014) Toll-like receptor signaling regulates cisplatin-induced mechanical allodynia in mice. Cancer Chemother Pharmacol 73:25-34

Showing the most recent 10 out of 102 publications